Cell Imaging News and Research

RSS

Researcher at Fox Chase Cancer Center wins a new Cytation™ 3 Cell Imaging Multi-Mode Reader in BioTek's "Think Possible" Application Contest

BioTek congratulates Dr. Jeff Peterson of the Fox Chase Cancer Center in Pennsylvania for winning a new Cytation™ 3 Cell Imaging Multi-Mode Reader in BioTek's "Think Possible" Application Contest. Entrants were judged on a short essay that they submitted, detailing the application that they think is possible for their specific research using the Cytation 3. As an Associate Professor, Dr. Peterson studies chemical biology and kinase signaling in cancer.

14 Apr 2014

Massachusetts Life Sciences Center provides $1.65M in capital grant to North Shore InnoVentures

North Shore InnoVentures, one of New England's leading technology incubators and business accelerators, announced today that it has received a capital grant of $1.65 million from the Massachusetts Life Sciences Center.

From Evident Corporation - Life Sciences 28 Mar 2014

BioTek to highlight latest microplate instrumentation technologies at Analytica 2014

BioTek Instruments, Inc., will highlight their latest microplate instrumentation technologies, designed to automate and improve lab efficiency, at Hall A3, Stand #310 during Analytica 2014, the 24th International Trade Fair for Laboratory Technology, Analysis and Biotechnology. The exhibition will be held April 1-4 at the Munich Trade Fair Centre / ICM in Munich, Germany.

28 Mar 2014

Imaging cancer in children using MRI: an interview with Dr. Heike E. Daldrup-Link, Stanford University School of Medicine

There have been a number of scientific publications recently that suggest that the radiation exposure from imaging tests can induce secondary cancers later in life.

21 Mar 2014

GE announces winners of the GE Healthcare 2013 Cell Imaging Competition

GE Healthcare Life Sciences (NYSE:GE) today announced Vanessa Auld from Canada, Martin Barr from Ireland and Graham Wright from Singapore as the winners of the GE Healthcare 2013 Cell Imaging Competition.

12 Mar 2014

BioTek wins Extraordinary New Product Line award for Cytation 3 Cell Imaging Multi-Mode Reader

BioTek Instruments, Inc., received Thermo Fisher Scientific's "Extraordinary New Product Line" award for their Cytation 3 Cell Imaging Multi-Mode Reader. The award was presented at the Fisher Scientific North America Sales Meeting, held February 24-26, 2014 in Denver, Colorado. Cytation 3 was recognized by Fisher Scientific's product management team for its innovative technology and successful sales performance.

4 Mar 2014

Deficiency in SNX27 explains learning impairment in Down's syndrome

Scientists at A*STAR's Institute of Molecular and Cell Biology (IMCB) have identified the precise role of the protein, SNX27, in the pathway leading to memory and learning impairment.

20 Feb 2014

Taste receptors act as first line sentinels against infection in upper airway

The body uses mucus as a protective barrier to defend against pathogens, toxins, and allergens in the upper respiratory tract that can lead to such conditions as chronic sinusitis.

19 Feb 2014

Phasefocus’ KTP associate Dr Suman receives runners up spot for Cellular Heaven and Hell time-lapse video

Phase Focus Ltd (Phasefocus), the company that is revolutionizing microscopy and imaging with the Phasefocus Virtual Lens® technology, reports on the Celldance competition results held at the recent annual ASCB meeting. KTP associate, Dr Rakesh Suman, was runner up with his video entitled "Cellular Heaven & Hell."

From Phase Focus Limited 18 Feb 2014

BioTek's Cytation 3 Cell Imaging Multi-Mode Reader is finalist in 2014 Edison Awards competition

BioTek Instruments, Inc., proudly announces that their Cytation 3 Cell Imaging Multi-Mode Reader is a finalist in the 2014 Edison Awards competition.

14 Feb 2014

Virtual Lens series of label-free live cell imaging systems announced by Phasefocus

Phase Focus Ltd (Phasefocus), the company that is revolutionising microscopy and imaging with the Phasefocus Virtual Lens®, announces the availability of the Virtual Lens series of label-free live cell imaging systems.

From Phase Focus Limited 4 Feb 2014

Phasefocus reports on new ptychography paper published in Nature Scientific Reports

Cell imaging often relies on synthetic or genetic fluorescent labels, to provide contrast which can be far from ideal for imaging cells in their in vivo state. We report on the biological application of a label-free, high contrast microscopy technique known as ptychography, in which the image producing step is transferred from the microscope lens to a high-speed phase retrieval algorithm.

From Phase Focus Limited 28 Jan 2014

VisionGate's Cell-CT platform can detect lung cancer in sputum samples with high specificity

VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer, today reported clinical data showing that its automated 3D cell imaging platform, the Cell-CT-, can detect lung cancer in sputum samples with high sensitivity and specificity. The data was presented at the International Association for the Study of Lung Cancer 15th World Conference on Lung Cancer.

29 Oct 2013

BioTek’s cell imaging multi-mode reader wins New Product Innovation Award

BioTek’s Cytation™3 Cell Imaging Multi-Mode Reader was recently honored with the first annual New Product Innovation Award, given by MipTec organizers at the 2013 MipTec Conference & Exhibition in Basel, Switzerland. Cytation3 was one of three winning products announced at the exhibition on September 25, 2013.

4 Oct 2013

Life science products from AXT to be exhibited at ComBio 2013

AXT, Australia’s leading supplier of analytical and sample preparation equipment will be exhibiting at the ComBio 2013 conference from September 29 to October 3, at the Perth Convention and Exhibition Centre, Western Australia, organised by the Australian Society for Biochemistry and Molecular Biology.

18 Sep 2013

Prairie Technologies acquired by Bruker

Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker’s position in life science markets, adding to the Bruker Nano Surfaces Division’s existing life science atomic force microscopy (Bio-AFM) systems.

From Bruker Nano Surfaces and Metrology 13 Sep 2013

BioTek's Cytation3 Cell Imaging Multi-Mode Reader recognized by SelectScience

For the second year in a row, BioTek Instruments was announced as winner of the SelectScience "Scientists' Choice Award for Best Drug Discovery Product". The award was given for BioTek's new Cytation3 Cell Imaging Multi-Mode Reader, and was announced at ELRIG Drug Discovery in Manchester, UK.

12 Sep 2013

Olympus to showcase next generation of inverted microscope systems at EMBO Meeting 2013

Demonstrating the very latest in live cell imaging technologies, Olympus will exhibit its range of IX3 inverted microscope frames with associated software and accessories at the upcoming European Molecular Biology Organisation Meeting 2013, taking place in Amsterdam on 21-24 September.

From Evident Corporation - Life Sciences 5 Sep 2013

PerkinElmer enhances Operetta imaging system to perform live cell assays with higher throughput

PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, has announced enhancements for its Operetta® High Content Imaging System, designed to significantly improve the ability of scientists to perform live cell assays with higher throughput, to help foster a better understanding of normal and aberrant cellular behavior.

25 Jul 2013

Hybrid molecular imaging technique helps doctors identify diabetic foot infection

Researchers are kick-starting better diabetic foot care and promoting reduced radiation dose with a new take on a hybrid molecular imaging technique. By targeting both bone cell activity and immune response and improving imaging data interpretation, doctors can better distinguish diabetic foot infection from another common foot condition that often requires an additional bone-marrow scan for definitive diagnosis, say researchers presenting a study at the Society of Nuclear Medicine and Molecular Imaging's 2013 Annual Meeting.

12 Jun 2013